FIELD: chemistry.
SUBSTANCE: present invention relates to dasatinib salts in amorphous form. Dasatinib salt contains the cation of a compound of formula 1, known as dasatinib, and the anion of a second compound selected from a group consisting of saccharin, glutaric acid and nicotinic acid.
EFFECT: dasatinib salt of the invention is used as a medicament for the treatment of cancer, particularly chronic myelogenous leukemia and/or acute lymphoblastic leukemia complicated by the Philadelphia chromosome.
7 cl, 3 dwg, 3 tbl, 7 ex
формула 1 - formula 1
| Title |
Year |
Author |
Number |
| DASATINIB SALTS IN CRYSTALLINE FORM |
2014 |
- Khafner Andreas
- Blatter Fritts
- Shelagevich Martin
- Zibenkhaar Bernd
- Chiodo Titsiana
- Khintermann Tobias
- Salvador Beate
- Fossen Markus
|
RU2662805C2 |
| 3-[1,2,3,6-TETRAHYDROPYRIDIN-2-YL]PYRIDINE GLUTARATE OR PHARMACEUTICALLY ACCEPTABLE SOLVATE THEREOF |
2019 |
|
RU2823979C2 |
| METHOD OF PRODUCING N-[5-(3,5-DIFTORBENZIL)-1H-INDAZOLE-3-YL]-4-(4-METHYLPIPERAZINE-1-YL)-2-(TETRAHYDROPYRAN-4-YLAMINO)BENZAMIDE |
2013 |
- Barbudzhan Natale Alvaro
- Forino Romualdo
- Orsini Paolo
|
RU2602071C2 |
| POLYMORPHOUS AND AMORPHOUS FORMS OF {2-FLUORINE-5-[3-((E)-2-PYRIDINE-2-ILVINYL)-1N-INDAZOLE-6-ILAMINE]PHENYL}AMIDE 2, 5-DIMETHYL-2N-PYRAZOLE-3-CARBONIC ACID |
2005 |
- E Tsjan'
- Zuk Skott Ehdvard
- Oullet Majkl Allen
- Khettinger Donald Nikolas
- Srirangam Dzhajaram Kasturi
- Kanija Robert Stiven
- Saeed Nabil' Lauze
- Uajtlin Mehtt'Ju Dehvid
- Mitchell Mark Brajan
|
RU2324692C1 |
| FORM IV OF IVABRADINE HYDROCHLORIDE |
2012 |
- Prohens Lopez Rafel
- Puigjaner Vallet Cristina
- Barbas Canero Rafael
- Del Rio Pericacho Jose Luis
- Marti Via Josep
|
RU2619121C2 |
| SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-cd]INDOL-6-ONE |
2011 |
- Patrishija Ehnn Basford
- Antoni Majkl Kampeta
- Adam Dzhillmor
- Matt'Ju Kameron Dzhons
- Ehlefterois Kougoulos
- Suman Lutra
- Robert Uolton
|
RU2570198C2 |
| SALTS OF 1-(4-(2-((1-(3,4-DIFLUOROPHENYL)-1N-PYRAZOL-3-YL)METHOXY)ETHYL)PIPERAZIN-1-YL)ETHANONE |
2016 |
- Torrens-Jover Antoni
- Almansa Rosales Carmen
|
RU2727974C2 |
| NOVEL CRYSTALLINE FORMS OF SODIUM SALT OF (4-{4-[5-(6-TRIFLUOROMETHYL-PYRIDIN-3-YLAMINO)PYRIDIN-2-YL]PHENYL}CYCLOHEXYL) ACETIC ACID |
2011 |
|
RU2612556C2 |
| ISOLATED ORTHORHOMBIC CRYSTALLINE FORM OF 4-{6-ACETYL-3-[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO)PROPOXY]-2-PROPYLPHENOXY}-BUTYRIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
2004 |
- Lok Kennet Uolter
- Roi Dejvid Gregori
|
RU2317979C2 |
| MULTICOMPONENT CRYSTALS COMPRISING DASATINIB AND SELECTED COCRYSTAL FORMERS |
2013 |
- Chiodo Titsiana
- Khafner Andreas
- Khintermann Tobias
- Zalvador Beate
- Shelagevich Martin
- Blatter Fritts
- Zibenkhaar Bernd
- Fossen Markus
|
RU2650524C2 |
